French farmers dump MANURE in protest
Hundreds of farmers staged a protest in Toulouse Thursday, April 8 against the new Common Agricultural Policy and dumped tons of manure on the streets.
Festival said that ‘time has run out’ to stage event safely
Covid UK: coronavirus cases, deaths and vaccinations today. The latest daily updates on coronavirus cases in your local area and nationally. Check week-on-week changes across England, Scotland, Wales and Northern Ireland and the latest figures from public health authorities
France is first EU member state to start testing digital Covid travel certificate. French trial will be extended from 29 April to include vaccination certificates
The Premier League's all-time leading goalscorer Alan Shearer has voiced his opposition to the proposed European Super League, saying that the ESL had "chucked a grenade at the Premier League".
Wen Jiabao’s article appeared in a newspaper called the ‘Macau Herald’ was was posted on WeChat before its circulation was restricted
Prince Charles, Prince William and Princess Anne have all carried out some kind of engagement since Philip's death.
It is not yet known if B1617 is more dangerous or better able to escape immunity triggered by vaccination or natural infection
As Belfast reels after another night of violence on its streets, this bloodshed feels darkly reminiscent of the Troubles. Claire McNeilly reports
Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States, but they confirmed the vaccine’s benefits still outweighed the very small risks of recipients developing the unusual clots. The European Medicines Agency said a warning about the rare blood clots should be added to labels for Johnson & Johnson’s COVID-19 vaccine. The agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”Last week, Johnson & Johnson halted its European roll-out of the vaccine after U.S. officials recommended a pause in the vaccine, when they detected six very rare blood clot cases among nearly 7 million people who had been vaccinated.European officials said they considered all currently available evidence from the U.S., which consisted of eight reports of serious cases of rare blood clots associated with low blood platelets, including one death.Last week, J&J halted its European rollout of its one-dose vaccine after the U.S. Food and Drug Administration recommended officials pause its use while the rare blood clot cases are examined. Officials identified six cases of the highly unusual blood clots among nearly 7 million people who were immunized with the shot in the U.S.Johnson & Johnson advised European governments to store their doses until the EU drug regulator issued guidance on their use; widespread use of the shot in Europe has not yet started.The delay was a further blow to vaccination efforts in the European Union, which have been plagued by supply shortages, logistical problems and concerns over unusual blood clots also in a small number of people who received the AstraZeneca COVID-19 vaccine. Experts worry the temporary halt on J&J’s shot could further shake vaccine confidence and complicate worldwide COVID-19 immunization efforts.Blood clots in unusual parts of bodyLast week, South Africa suspended its use of the vaccine in the wake of the U.S. pause, and countries including Italy, Romania, the Netherlands, Denmark and Croatia put their J&J doses into storage.The blood clots linked to the J&J vaccine are occurring in unusual parts of the body, such as veins that drain blood from the brain. Those patients also have abnormally low levels of blood platelets, a condition normally linked to bleeding, not clotting.With the AstraZeneca vaccine, scientists in Norway and Germany have suggested that some people are experiencing an abnormal immune system response, forming antibodies that attack their own platelets.It’s not yet clear if there might be a similar mechanism with the Johnson & Johnson vaccine. But both the J&J and AstraZeneca vaccines, as well as a Russian COVID-19 vaccine and one from China, are made with the same technology. They train the immune system to recognize the spike protein that coats the coronavirus. To do that, they use a cold virus, called an adenovirus, to carry the spike gene into the body.“Suspicion is rising that these rare cases may be triggered by the adenovirus component of the AstraZeneca and J&J vaccines,” said Eleanor Riley, a professor of immunology and infectious diseases at the University of Edinburgh. She said that while more data was needed, “it remains the case that for the vast majority of adults in Europe and the USA, the risks associated with contracting COVID-19 far, far outweigh any risk of being vaccinated.”More than 5 million new cases last weekOn Monday, World Health Organization Director-General Tedros Adhanom Ghebreyesus said more than 5 million new cororavirus cases were confirmed worldwide last week, the highest-ever number in a single week. He noted that cases and hospitalizations among younger people were “increasing at an alarming rate.”The European Medicines Agency, which regulates drugs used in European Union member nations, said last month there was a “possible link” between the AstraZeneca vaccine and rare blood clots but said the benefits of vaccination far outweighed the risks of COVID-19. It noted the risk is less than the blood clot risk that healthy women face from birth control pills.The European Union ordered 200 million doses of the Johnson & Johnson for 2021 and EU officials had hoped the one-shot vaccine could be used both to boost the continent’s lagging vaccination rates and to protect hard-to-reach populations, like migrant workers and the homeless.Last month, the African Union announced it signed a deal to buy up to 400 million doses of the J&J vaccine. Johnson & Johnson also has a deal to supply up to 500 million doses to the U.N.-backed COVAX initiative that helps get vaccines to the world’s poor.Any concerns about the J&J vaccine would be another unwelcome complication for COVAX and for the billions of people in developing countries depending on the program. COVAX recently was hit by supply issues after its biggest supplier, the Serum Institute of India, announced it would delay exports of the AstraZeneca vaccine for several months due to a surge of cases on the subcontinent.(AP)
The congresswoman blames rogue staff for the platform document and said she never planned to launch anything
Landslide in North Wales follows Jurassic Coast and Dover rockfalls already this spring
Changes made at ‘short notice’ left police scrambling to enforce law, Sir Jonathan Jones QC says
He also announced a new “Antivirals Taskforce” to help develop take-at-home drugs to combat Covid-19
The 'Titanic' star's 20-year-old daughter Mia uses her father's name Threapleton, not Winslet.
It's not just vitamin D you might want to consider.
Despite doubts she’d ever achieve her career ‘dream’, Oscar winner will reportedly star in new Marvel series
Former president gives first sit down interview with major news network since he left for Florida
A new taskforce will be charged with identifying medicines by as early as the autumn.
"I felt similar to how Mandy feels in this series really."
Pictures from the new episode give hope to Vicky McClure fans.